FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Fludarabine Phosphate Injection
Status: Resolved
»Duration of Shortage: 05/06/2022 - 04/17/2024
»Therapeutic Categories: Oncology

Expand all

Areva Pharmaceuticals, Inc. (Revised 04/17/2024)

Company Contact Information:
812-399-0479

Presentation

• Injection, 25 mg/1 mL (NDC 59923-604-02)

Note:

• Available

Fresenius Kabi USA, LLC (Revised 04/17/2024)

Company Contact Information:
888-386-1300

Presentation

• Injection, 25 mg/1 mL (NDC 63323-192-02)

Note:

• Available

Teva Pharmaceuticals USA, Inc. (Revised 04/17/2024)

Company Contact Information:
800-545-8800

Presentation

• Fludarabine Phosphate for Injection, USP (Lyophilized), Injection, 50 mg/2 mL (NDC 45963-609-55)
• Fludarabine Phosphate for Injection, USP (Lyophilized), Injection, 25 mg/1 mL (NDC 45963-621-51)
• CYTOSTATIKUM Fludarabin Actavis 25 mg/ml, Injection, 25 mg/1 mL (NDC 0480-9772-01)

Note:

• Available